ATE231149T1 - (1,8)-naphthyridinderivate derivate mit antiviraler wirkung - Google Patents

(1,8)-naphthyridinderivate derivate mit antiviraler wirkung

Info

Publication number
ATE231149T1
ATE231149T1 AT00906096T AT00906096T ATE231149T1 AT E231149 T1 ATE231149 T1 AT E231149T1 AT 00906096 T AT00906096 T AT 00906096T AT 00906096 T AT00906096 T AT 00906096T AT E231149 T1 ATE231149 T1 AT E231149T1
Authority
AT
Austria
Prior art keywords
derivatives
naphthyridine
antiviral effect
hepatitis
virus
Prior art date
Application number
AT00906096T
Other languages
English (en)
Inventor
Benoit Bachand
Nghe Nguyen-Ba
Arshad Siddiqui
Sophie Levesque
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Application granted granted Critical
Publication of ATE231149T1 publication Critical patent/ATE231149T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00906096T 1999-02-22 2000-02-22 (1,8)-naphthyridinderivate derivate mit antiviraler wirkung ATE231149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12108099P 1999-02-22 1999-02-22
PCT/CA2000/000181 WO2000050424A1 (en) 1999-02-22 2000-02-22 [1,8] naphthyridine derivatives having antiviral activity

Publications (1)

Publication Number Publication Date
ATE231149T1 true ATE231149T1 (de) 2003-02-15

Family

ID=22394395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906096T ATE231149T1 (de) 1999-02-22 2000-02-22 (1,8)-naphthyridinderivate derivate mit antiviraler wirkung

Country Status (8)

Country Link
US (2) US6340690B1 (de)
EP (1) EP1155017B1 (de)
JP (1) JP2002537396A (de)
AT (1) ATE231149T1 (de)
AU (1) AU777040B2 (de)
CA (1) CA2364652A1 (de)
DE (1) DE60001218D1 (de)
WO (1) WO2000050424A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3705975B2 (ja) * 1999-11-26 2005-10-12 独立行政法人科学技術振興機構 ミスマッチ認識分子
JP2003532643A (ja) * 2000-04-13 2003-11-05 フアーマセツト・リミテツド 肝炎ウイルス感染症を治療するための3’−または2’−ヒドロキシメチル置換ヌクレオシド誘導体
MY164523A (en) * 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
PL359169A1 (en) * 2000-05-26 2004-08-23 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
US6936629B2 (en) 2001-12-21 2005-08-30 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of flavivirus infections
AU2003215826A1 (en) * 2002-04-01 2003-10-13 Pfizer Inc. Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
KR20050035194A (ko) * 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN101172993A (zh) * 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
EP2573079A3 (de) * 2002-08-23 2015-03-11 Novartis AG Benzimidazolchinolinonderivate und ihre Verwendung
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
US7598373B2 (en) * 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
DE10311563A1 (de) * 2003-03-17 2004-09-30 Bayer Healthcare Ag Replikationsassay zur Auffindung antiviraler Substanzen mit HTS Verfahren
ATE478886T1 (de) 2003-07-25 2010-09-15 Idenix Pharmaceuticals Inc Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
JP2007509057A (ja) * 2003-10-15 2007-04-12 カイロン コーポレイション ウイルス阻害のための組成物および方法
DK2666481T3 (en) * 2003-12-26 2019-02-25 Masatoshi Hagiwara A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient
US20060040944A1 (en) * 2004-06-23 2006-02-23 Gilles Gosselin 5-Aza-7-deazapurine derivatives for treating Flaviviridae
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
TWI385169B (zh) * 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
US7781576B2 (en) * 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
WO2008035726A1 (en) 2006-09-21 2008-03-27 Eisai R & D Management Co., Ltd. Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
EP1972627A1 (de) * 2007-03-19 2008-09-24 Technische Universität Carolo-Wilhelmina zu Braunschweig Aminonaphthyridin-Derivate
US8513420B2 (en) 2007-03-19 2013-08-20 Monika Mazik Amino-naphthyridine derivatives
CN101622251B (zh) 2007-04-27 2012-07-04 卫材R&D管理有限公司 杂环取代吡啶衍生物的盐或其结晶
TW200841879A (en) * 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
US8513287B2 (en) * 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
JP2012176900A (ja) * 2009-06-24 2012-09-13 Eisai R & D Management Co Ltd ((ホスホノオキシ)メチル)ピリジニウム環を有するピリジン誘導体およびそれらを含有する抗真菌剤
KR101317656B1 (ko) 2011-06-30 2013-10-15 연세대학교 산학협력단 복제효소 인산화를 조절하는 신규 c형 간염 예방 또는 치료용 조성물
WO2013056003A2 (en) 2011-10-12 2013-04-18 Yale University Catechol diethers as potent anti-hiv agents
EP3720438B1 (de) 2017-12-07 2023-08-30 Amplyx Pharmaceuticals, Inc. Heterozyklus-substituierte pyridinderivatantimykotika

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2263752A1 (en) 1974-03-14 1975-10-10 Rhone Poulenc Ind 1,8-Naphthyridine derivs - tranquillizers and anti-convulsants
FR2567887B1 (fr) * 1984-07-19 1986-12-19 Rhone Poulenc Sante Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
CA1265803A (fr) 1985-07-11 1990-02-13 Claude Cotrel Amides substitues, leur preparation et les medicaments qui les contiennent
FR2592882B2 (fr) 1986-01-16 1988-03-11 Rhone Poulenc Sante Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
US4753941A (en) 1986-01-16 1988-06-28 Rhone-Poulenc Sante Amides based on certain 1,8-naphtyridine-2-amines useful as anxiolytics
DE3907938A1 (de) 1989-03-11 1990-09-13 Basf Ag 2,3-substituierte 1,8-naphthyridine, verfahren zu ihrer herstellung und ihre verwendung als antidots
FR2676056B1 (fr) 1991-05-03 1993-07-16 Adir Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CA2123728A1 (en) * 1993-05-21 1994-11-22 Noriyoshi Sueda Urea derivatives and their use as acat inhibitors
GB9605437D0 (en) 1996-03-15 1996-05-15 Iaf Biochem Int Cytomegalovirus inhibiting compounds
WO1997034870A1 (en) * 1996-03-22 1997-09-25 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands

Also Published As

Publication number Publication date
US6340690B1 (en) 2002-01-22
JP2002537396A (ja) 2002-11-05
EP1155017B1 (de) 2003-01-15
CA2364652A1 (en) 2000-08-31
US20020099072A1 (en) 2002-07-25
AU2788300A (en) 2000-09-14
US6605614B2 (en) 2003-08-12
WO2000050424A1 (en) 2000-08-31
AU777040B2 (en) 2004-09-30
EP1155017A1 (de) 2001-11-21
DE60001218D1 (de) 2003-02-20

Similar Documents

Publication Publication Date Title
DE60001218D1 (de) [1,8]-naphthyridinderivate derivate mit antiviraler wirkung
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
NO20034595D0 (no) Kinolin- og kinazolinderivater med azolylgruppe
BG101422A (bg) Бензоксазолни производни като бронхоразширяващи средства
EA200100757A1 (ru) Хинолинкарбоксамиды в качестве противовирусных агентов
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
PT897904E (pt) 2-metoxibenzofenonas fungicidas
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
DK1200418T3 (da) Nematodicide trifluorbutener
FI902555A0 (fi) Diarylstyrylkinolindisyror.
DE60121461D1 (de) Kondensierte pyridoindolderivate
EP1422225A4 (de) Benzoisoselenazolderivate mit entzündungshemmender, antiviraler und antithrombotischer wirkung und deren verwendungen
EA199900163A1 (ru) Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
DE60112960D1 (de) Kondensierte pyridoindolderivate
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
ES2102772T3 (es) Compuesto citotoxico y antiviral.
DE3873278D1 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
EA200200749A1 (ru) Производные гетероциклического амида
DK1392672T3 (da) Chlormethylering af thiopen
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties